Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression
BicycleTx Limited
BicycleTx Limited
Maastricht University Medical Center
DEKA Biosciences
UNICANCER
University Hospital, Ghent
Fate Therapeutics
Jules Bordet Institute
Five Prime Therapeutics, Inc.